Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirofumi Jono

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2018
[Establishing Individualized Medicine for Intractable Cancer Based on Clinical Molecular Pathogenesis]Hirofumi Jono
Cancers|November 28, 2013
Midkine: a novel prognostic biomarker for cancerHirofumi Jono, Yukio Ando
Biological & Pharmaceutical Bulletin|December 4, 2018
Recent Advances in Oligonucleotide-Based Therapy for Transthyretin Amyloidosis: Clinical Impact and Future ProspectsYuya Hayashi, Hirofumi Jono
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 12, 2008
[Pathogenesis and therapy for transthyretin related amyloidosis]Yukio Ando, Hirofumi Jono
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 10, 2026
Effect of body composition on initial teicoplanin dosing and optimization of the regimenShoji Kondo, Kazutaka Oda, Hirofumi Jono
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
IntroductionYukio Ando, Mitsuharu Ueda, Hirofumi Jono
Pharmacology & Therapeutics|May 6, 2023
Bayesian prediction-based individualized dosing of anti-methicillin-resistant Staphylococcus aureus treatment: Recent advancements and prospects in therapeutic drug monitoringKazutaka Oda, Hideyuki Saito, Hirofumi Jono
Therapeutic Drug Monitoring|July 1, 2024
Optimizing Cefiderocol Dosing Through Population Pharmacokinetic/Pharmacodynamic Simulation: An Assessment of Drug Cost ReductionsKazutaka Oda, Hirofumi Jono, Hideyuki Saito
Antimicrobial Agents and Chemotherapy|May 17, 2023
Model-Informed Precision Dosing of Vancomycin in Adult Patients Undergoing HemodialysisKazutaka Oda, Hirofumi Jono, Hideyuki Saito
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 27, 2020
Augmented teicoplanin clearance through probable adsorption onto a polymethyl methacrylate (PMMA) hemofilter during continuous venovenous hemodiafiltrationKazutaka Oda, Hirofumi Jono, Katsuyuki Sagishima, et al.
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2018
[Establishing Individualized Medicine for Intractable Cancer Based on Clinical Molecular Pathogenesis]Hirofumi Jono
Cancers|November 28, 2013
Midkine: a novel prognostic biomarker for cancerHirofumi Jono, Yukio Ando
Biological & Pharmaceutical Bulletin|December 4, 2018
Recent Advances in Oligonucleotide-Based Therapy for Transthyretin Amyloidosis: Clinical Impact and Future ProspectsYuya Hayashi, Hirofumi Jono
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 12, 2008
[Pathogenesis and therapy for transthyretin related amyloidosis]Yukio Ando, Hirofumi Jono
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 10, 2026
Effect of body composition on initial teicoplanin dosing and optimization of the regimenShoji Kondo, Kazutaka Oda, Hirofumi Jono
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
IntroductionYukio Ando, Mitsuharu Ueda, Hirofumi Jono
Pharmacology & Therapeutics|May 6, 2023
Bayesian prediction-based individualized dosing of anti-methicillin-resistant Staphylococcus aureus treatment: Recent advancements and prospects in therapeutic drug monitoringKazutaka Oda, Hideyuki Saito, Hirofumi Jono
Therapeutic Drug Monitoring|July 1, 2024
Optimizing Cefiderocol Dosing Through Population Pharmacokinetic/Pharmacodynamic Simulation: An Assessment of Drug Cost ReductionsKazutaka Oda, Hirofumi Jono, Hideyuki Saito
Antimicrobial Agents and Chemotherapy|May 17, 2023
Model-Informed Precision Dosing of Vancomycin in Adult Patients Undergoing HemodialysisKazutaka Oda, Hirofumi Jono, Hideyuki Saito
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 27, 2020
Augmented teicoplanin clearance through probable adsorption onto a polymethyl methacrylate (PMMA) hemofilter during continuous venovenous hemodiafiltrationKazutaka Oda, Hirofumi Jono, Katsuyuki Sagishima, et al.
Pageof 16